Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology Pune, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Gene Therapy Market Size & Growth Overview: “According to SNS Insider, The Gene Therapy Market Size was valued at USD 9.2 Billion in 2023 and is...

[Latest] Global Gene Therapy Market Size/Share Worth USD 7247.58 Million by 2028 at a 20.10% CAGR: Facts & Factors (Industrial Trends, Report, Analysis, Players, Outlook, Forecast, Growth, CAGR, Overview, Value, Segmentation) SAN FRANCISCO, U.S., Feb. 17, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Gene Therapy Market Size, Share, Growth Analysis Report By Vector Type (Viral...

Gene Therapy Market Report (2022 to 2030) - Novartis AG, Spark Therapeutics Inc. (Roche), Gilead Sciences Inc., Biogen Inc., Avita Medical, Jazz Pharmaceuticals Plc. and Celgene Corporation 20 Maxwell House, Singapore, Jan. 25, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global gene therapy market is expected to clock US$ 4.64 billion...

Gene Therapy Market Worth USD 35.67 Billion at 33.6% CAGR; Rising Prevalence of Spinal Muscular Atrophy to Augment Growth: Fortune Business Insights™ Pune, India, Dec. 14, 2020 (GLOBE NEWSWIRE) -- The report mentions that the Gene Therapy Market size was USD 3.61 billion in 2019 and is projected to reach USD 35.67 billion by 2027, exhibiting a...